The DOI matches its Crossref record.
The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening
Open accessAbstract
An interval breast cancer is a cancer that emerges following a negative mammographic screen. This overview describes the epidemiology, and the radiological and biological characteristics of interval breast cancers in population mammography screening. Notwithstanding possible differences in ascertainment of interval breast cancers, there was broad variability in reported interval breast cancer rates (range 7.0 to 49.3 per 10,000 screens) reflecting heterogeneity in underlying breast cancer rates, screening rounds (initial or repeat screens), and the length and phase of the inter-screening interval. The majority of studies (based on biennial screening) reported interval breast cancer rates in the range of 8.4 to 21.1 per 10,000 screens spanning the two-year interval with the larger proportion occurring in the second year. Despite methodological limitations inherent in radiological surveillance (retrospective mammographic review) of interval breast cancers, this form of surveillance consistently reveals that the majority of interval cancers represent either true interval or occult cancers that were not visible on the index mammographic screen; approximately 20–25% of interval breast cancers are classified as having been missed (false-negatives). The biological characteristics of interval breast cancers show that they have relatively worse tumour prognostic characteristics and biomarker profile, and also survival outcomes, than screen-detected breast cancers; however, they have similar characteristics and prognosis as breast cancers occurring in non-screened women. There was limited evidence on the effect on interval breast cancer frequency and outcomes following transition from film to digital mammography screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
International evaluation of an AI system for breast cancer screening
McKinney, S. M., Sieniek, M., Godbole, V., Godwin, J., Antropova, N., Ashrafian, H., Back, T., Chesus, M., Corrado, G. S., Darzi, A., et al. (2020) · Nature · doi:10.1038/s41586-019-1799-6 · Cited by 3,287
Lång, K., Josefsson, V., Larsson, A.-M., Larsson, S., Högberg, C., Sartor, H., Hofvind, S., Andersson, I., & Rosso, A. (2023) · The Lancet Oncology · doi:10.1016/s1470-2045(23)00298-x · Cited by 598
Freeman, K., Geppert, J., Stinton, C., Todkill, D., Johnson, S., Clarke, A., & Taylor-Phillips, S. (2021) · BMJ · doi:10.1136/bmj.n1872 · Cited by 338
Artificial intelligence in breast imaging
Le, E. P. V., Wang, Y., Huang, Y., Hickman, S., & Gilbert, F. J. (2019) · Clinical Radiology · doi:10.1016/j.crad.2019.02.006 · Cited by 276
Hernström, V., Josefsson, V., Sartor, H., Schmidt, D., Larsson, A.-M., Hofvind, S., Andersson, I., Rosso, A., Hagberg, O., & Lång, K. (2025) · The Lancet Digital Health · doi:10.1016/s2589-7500(24)00267-x · Cited by 174
Metadata
- Authors
- Houssami, N., & Hunter, K.
- Venue
- npj Breast Cancer
- Published
- 2017-04-13
- Volume
- 3
- Issue
- 1
- Pages
- 12-12
- ISSN
- 2374-4677 (ISSN-L)
- OpenAlex
- W2604957907
- Cited by
- 223
- References
- 0
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening. https://app.cochat.ai/papers/10.1038/s41523-017-0014-x
- The paper
- Houssami, N., & Hunter, K. (2017). The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening. npj Breast Cancer. https://doi.org/10.1038/s41523-017-0014-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.